The author discusses aspects of the radiation induced sarcoma (RIS). Topics include the advances in radiation therapy which have resulted in improvement regarding the survival and disease free survival of solid tumors, the pre-irradiation malignant tumors, and the need for further research to determine the risk for RIS development.